Copyright Reports & Markets. All rights reserved.

Global Dexlansoprazole API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Dexlansoprazole API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Dexlansoprazole API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Dexlansoprazole Capsules
    • 1.4.3 Others
  • 1.5 Global Dexlansoprazole API Market Size & Forecast
    • 1.5.1 Global Dexlansoprazole API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Dexlansoprazole API Sales Quantity (2020-2031)
    • 1.5.3 Global Dexlansoprazole API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Piramal Enterprises Limited
    • 2.1.1 Piramal Enterprises Limited Details
    • 2.1.2 Piramal Enterprises Limited Major Business
    • 2.1.3 Piramal Enterprises Limited Dexlansoprazole API Product and Services
    • 2.1.4 Piramal Enterprises Limited Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Piramal Enterprises Limited Recent Developments/Updates
  • 2.2 Metrochem API Private Limited
    • 2.2.1 Metrochem API Private Limited Details
    • 2.2.2 Metrochem API Private Limited Major Business
    • 2.2.3 Metrochem API Private Limited Dexlansoprazole API Product and Services
    • 2.2.4 Metrochem API Private Limited Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Metrochem API Private Limited Recent Developments/Updates
  • 2.3 Zhejiang Hengkang Pharmaceutical
    • 2.3.1 Zhejiang Hengkang Pharmaceutical Details
    • 2.3.2 Zhejiang Hengkang Pharmaceutical Major Business
    • 2.3.3 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product and Services
    • 2.3.4 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
  • 2.4 Lupin Ltd
    • 2.4.1 Lupin Ltd Details
    • 2.4.2 Lupin Ltd Major Business
    • 2.4.3 Lupin Ltd Dexlansoprazole API Product and Services
    • 2.4.4 Lupin Ltd Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Lupin Ltd Recent Developments/Updates
  • 2.5 Dipharma
    • 2.5.1 Dipharma Details
    • 2.5.2 Dipharma Major Business
    • 2.5.3 Dipharma Dexlansoprazole API Product and Services
    • 2.5.4 Dipharma Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Dipharma Recent Developments/Updates
  • 2.6 Optimus Pharma P Limited
    • 2.6.1 Optimus Pharma P Limited Details
    • 2.6.2 Optimus Pharma P Limited Major Business
    • 2.6.3 Optimus Pharma P Limited Dexlansoprazole API Product and Services
    • 2.6.4 Optimus Pharma P Limited Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Optimus Pharma P Limited Recent Developments/Updates
  • 2.7 Orchid Chemicals & Pharmaceuticals
    • 2.7.1 Orchid Chemicals & Pharmaceuticals Details
    • 2.7.2 Orchid Chemicals & Pharmaceuticals Major Business
    • 2.7.3 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product and Services
    • 2.7.4 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Orchid Chemicals & Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Dexlansoprazole API by Manufacturer

  • 3.1 Global Dexlansoprazole API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Dexlansoprazole API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Dexlansoprazole API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Dexlansoprazole API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Dexlansoprazole API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Dexlansoprazole API Manufacturer Market Share in 2024
  • 3.5 Dexlansoprazole API Market: Overall Company Footprint Analysis
    • 3.5.1 Dexlansoprazole API Market: Region Footprint
    • 3.5.2 Dexlansoprazole API Market: Company Product Type Footprint
    • 3.5.3 Dexlansoprazole API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Dexlansoprazole API Market Size by Region
    • 4.1.1 Global Dexlansoprazole API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Dexlansoprazole API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Dexlansoprazole API Average Price by Region (2020-2031)
  • 4.2 North America Dexlansoprazole API Consumption Value (2020-2031)
  • 4.3 Europe Dexlansoprazole API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Dexlansoprazole API Consumption Value (2020-2031)
  • 4.5 South America Dexlansoprazole API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Dexlansoprazole API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 5.2 Global Dexlansoprazole API Consumption Value by Type (2020-2031)
  • 5.3 Global Dexlansoprazole API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 6.2 Global Dexlansoprazole API Consumption Value by Application (2020-2031)
  • 6.3 Global Dexlansoprazole API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 7.2 North America Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 7.3 North America Dexlansoprazole API Market Size by Country
    • 7.3.1 North America Dexlansoprazole API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Dexlansoprazole API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Dexlansoprazole API Market Size by Country
    • 8.3.1 Europe Dexlansoprazole API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Dexlansoprazole API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Dexlansoprazole API Market Size by Region
    • 9.3.1 Asia-Pacific Dexlansoprazole API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Dexlansoprazole API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 10.2 South America Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 10.3 South America Dexlansoprazole API Market Size by Country
    • 10.3.1 South America Dexlansoprazole API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Dexlansoprazole API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Dexlansoprazole API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Dexlansoprazole API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Dexlansoprazole API Market Size by Country
    • 11.3.1 Middle East & Africa Dexlansoprazole API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Dexlansoprazole API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Dexlansoprazole API Market Drivers
  • 12.2 Dexlansoprazole API Market Restraints
  • 12.3 Dexlansoprazole API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Dexlansoprazole API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Dexlansoprazole API
  • 13.3 Dexlansoprazole API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Dexlansoprazole API Typical Distributors
  • 14.3 Dexlansoprazole API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dexlansoprazole API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Dexlansoprazole is used to heal and maintain healing of erosive esophagitis and to treat heartburn associated with gastroesophageal reflux disease (GERD). It lasts longer than lansoprazole, to which it is chemically related, and needs to be taken less often. There is no good evidence that it works better than other PPIs.
    This report is a detailed and comprehensive analysis for global Dexlansoprazole API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dexlansoprazole API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dexlansoprazole API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dexlansoprazole API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Dexlansoprazole API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dexlansoprazole API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dexlansoprazole API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Metrochem API Private Limited, Zhejiang Hengkang Pharmaceutical, Lupin Ltd, Dipharma, Optimus Pharma P Limited, Orchid Chemicals & Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Dexlansoprazole API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥98%
    Purity<98%
    Market segment by Application
    Dexlansoprazole Capsules
    Others
    Major players covered
    Piramal Enterprises Limited
    Metrochem API Private Limited
    Zhejiang Hengkang Pharmaceutical
    Lupin Ltd
    Dipharma
    Optimus Pharma P Limited
    Orchid Chemicals & Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Dexlansoprazole API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Dexlansoprazole API, with price, sales quantity, revenue, and global market share of Dexlansoprazole API from 2020 to 2025.
    Chapter 3, the Dexlansoprazole API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Dexlansoprazole API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dexlansoprazole API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Dexlansoprazole API.
    Chapter 14 and 15, to describe Dexlansoprazole API sales channel, distributors, customers, research findings and conclusion.

    Buy now